- Home
- ARDX vs MQY Comparison
ARDX vs MQY Comparison
Compare ARDX & MQY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARDX
- MQY
- Stock Information
- Founded
- ARDX 2007
- MQY 1994
- Country
- ARDX United States
- MQY United States
- Employees
- ARDX N/A
- MQY N/A
- Industry
- ARDX Biotechnology: Pharmaceutical Preparations
- MQY Investment Bankers/Brokers/Service
- Sector
- ARDX Health Care
- MQY Finance
- Exchange
- ARDX Nasdaq
- MQY Nasdaq
- Market Cap
- ARDX 885.2M
- MQY 786.6M
- IPO Year
- ARDX 2014
- MQY N/A
- Fundamental
- Price
- ARDX $3.93
- MQY $11.11
- Analyst Decision
- ARDX Strong Buy
- MQY
- Analyst Count
- ARDX 9
- MQY 0
- Target Price
- ARDX $10.17
- MQY N/A
- AVG Volume (30 Days)
- ARDX 4.6M
- MQY 184.8K
- Earning Date
- ARDX 07-31-2025
- MQY 01-01-0001
- Dividend Yield
- ARDX N/A
- MQY 4.73%
- EPS Growth
- ARDX N/A
- MQY N/A
- EPS
- ARDX N/A
- MQY N/A
- Revenue
- ARDX $361,706,000.00
- MQY N/A
- Revenue This Year
- ARDX $12.01
- MQY N/A
- Revenue Next Year
- ARDX $34.66
- MQY N/A
- P/E Ratio
- ARDX N/A
- MQY N/A
- Revenue Growth
- ARDX 127.33
- MQY N/A
- 52 Week Low
- ARDX $3.21
- MQY $9.82
- 52 Week High
- ARDX $8.06
- MQY $12.52
- Technical
- Relative Strength Index (RSI)
- ARDX 57.99
- MQY 58.20
- Support Level
- ARDX $3.49
- MQY $10.92
- Resistance Level
- ARDX $3.72
- MQY $11.04
- Average True Range (ATR)
- ARDX 0.16
- MQY 0.06
- MACD
- ARDX 0.06
- MQY 0.03
- Stochastic Oscillator
- ARDX 98.21
- MQY 85.22
About ARDX Ardelyx Inc.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
About MQY Blackrock MuniYield Quality Fund Inc.
Blackrock Muniyield Quality Fund Inc is a closed-end management investment company. The company's objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in Transportation, Corporate, Health, Utilities, Education, Housing, and other sectors.